Adler Reid G.
SEC CIK 1924908 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | CLO | 60.9K | $51.0K | — | 6 | 2022-08-17 | 2026-06-30 |
Most active insiders at VTGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Prince Joshua S. | COO | — | — |
| 2 | Adler Reid G. | CLO | — | — |
| 3 | Tressler Nick B. | CFO | — | — |
| 4 | Singh Shawn | Pres, CEO, Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 16:34 | 2026-06-30 | VTGN | Vistagen Therapeutics, Inc. | Adler Reid G. | CLO | A - Grant | $0.1921 | +36.8K | 60.9K | +153% | +$7,073 | |
| 2025-07-01 | 2025-06-30 | VTGN | Vistagen Therapeutics, Inc. | Adler Reid G. | CLO | A - Grant | $1.70 | +7,541 | 24.1K | +46% | +$12.8K | |
| 2024-07-02 | 2024-06-28 | VTGN | Vistagen Therapeutics, Inc. | Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | A - Grant | $2.96 | +4,854 | 16.5K | +42% | +$14.4K | |
| 2024-01-03 | 2023-12-29 | VTGN | Vistagen Therapeutics, Inc. | Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | A - Grant | $1.72 | +167 | 11.7K | +1% | +$287.24 | |
| 2023-07-05 | 2023-06-30 | VTGN | Vistagen Therapeutics, Inc. | Adler Reid G. | CLO | A - Grant | $1.59 | +167 | 11.5K | +1% | +$265.53 | |
| 2022-08-19 | 2022-08-17 | VTGN | Vistagen Therapeutics, Inc. | Adler Reid G. | CLO | P - Purchase | $0.17 | +300.0K | 334.6K | +866% | +$51.0K |
Purchase Sale Sale after option exercise All abbreviations